MarketCap
Facebook
X
TelegramQuarterly report 2025-Q1
added 05-20-2025
Ontrak Cost of Revenue 2011-2025 | OTRK
Cost of Revenue is a financial metric that reflects all direct costs associated with the production of goods or the provision of services that directly led to revenue during the reporting period. It is the total amount of expenses incurred by the company to deliver its products or services, including both production costs and related expenses necessary for delivery or customer support.What is included in the cost of revenue
| Cost Category | Examples |
|---|---|
| Production Costs | Materials, wages of production staff, depreciation of equipment |
| Service and Support | Customer service, user support, technical assistance |
| Delivery and Logistics | Packaging, delivery of goods to customers |
| Hosting and Infrastructure | Servers, cloud platforms (especially for IT and SaaS companies) |
| Content and Licenses | License purchases, production royalties (e.g., in streaming services) |
Importance of the Metric
- Helps to understand how costly the revenue-generating process is.
- A high cost of revenue may indicate:
Poor cost control
Low operational efficiency - A low cost of revenue combined with high revenue indicates high profitability and business competitiveness.
Annual Cost of Revenue Ontrak
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.02 M | 3.94 M | 7.46 M | 31.2 M | 43.6 M | 20.4 M | 11.1 M | 6.39 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 43.6 M | 3.94 M | 16 M |
Quarterly Cost of Revenue Ontrak
| 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.27 M | - | 975 K | 844 K | 975 K | - | 1.04 M | 804 K | 847 K | - | 1.44 M | 2.21 M | 2.85 M | - | 5.86 M | 8.52 M | 12.8 M | - | 13.1 M | 9.88 M | 7.23 M | - | 6.12 M | 4.36 M | 3.03 M | - | 3.24 M | 2.94 M | 2.29 M | - | 1.66 M | 1.33 M | 1.36 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 13.1 M | 804 K | 3.88 M |
Cost of Revenue of other stocks in the Care facilities industry
| Issuer | Cost of Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
American Shared Hospital Services
AMS
|
19.2 M | $ 2.11 | 1.44 % | $ 13.7 M |  USA |
 |
Avalon GloboCare Corp.
AVCO
|
1.43 M | - | 26.45 % | $ 70.6 M | USA |
 |
Concord Medical Services Holdings Limited
CCM
|
463 M | $ 4.12 | -7.62 % | $ 540 M |  China |
 |
Fresenius Medical Care AG & Co. KGaA
FMS
|
12.5 B | $ 23.53 | 0.64 % | $ 7.05 B |  Germany |
 |
Chemed Corporation
CHE
|
1.58 B | $ 428.21 | -0.22 % | $ 6.43 B | USA |
 |
Acadia Healthcare Company
ACHC
|
1.69 B | $ 14.2 | -1.73 % | $ 1.3 B | USA |
 |
Amedisys
AMED
|
1.33 B | - | 0.01 % | $ 3.3 B | USA |
 |
Apollo Medical Holdings
AMEH
|
1.17 B | - | -2.11 % | $ 1.84 B | USA |
 |
AMN Healthcare Services
AMN
|
2.54 B | $ 16.38 | 0.68 % | $ 642 M | USA |
 |
Aesthetic Medical International Holdings Group Limited
AIH
|
376 M | - | 10.96 % | $ 46.2 M | China |
 |
Community Health Systems
CYH
|
1.95 B | $ 3.24 | -1.37 % | $ 428 M | USA |
 |
Elanco Animal Health Incorporated
ELAN
|
2 B | $ 21.32 | 0.24 % | $ 10.5 B | USA |
 |
The Joint Corp.
JYNT
|
9.17 M | $ 8.74 | -2.67 % | $ 127 M | USA |
 |
HCA Healthcare
HCA
|
29.5 B | $ 483.48 | 0.23 % | $ 132 B | USA |
 |
Addus HomeCare Corporation
ADUS
|
780 M | $ 114.75 | 0.34 % | $ 1.95 B | USA |
 |
The Ensign Group
ENSG
|
3.38 B | $ 175.65 | 0.86 % | $ 9.95 B | USA |
 |
Hanger
HNGR
|
398 M | - | - | $ 732 M | USA |
 |
IMAC Holdings
IMAC
|
305 K | - | -1.77 % | $ 25.4 M | USA |
 |
Encompass Health Corporation
EHC
|
2.9 B | $ 106.94 | 0.08 % | $ 10.7 B | USA |
 |
MEDNAX
MD
|
1.54 B | $ 22.27 | 0.72 % | $ 1.86 B | USA |
 |
National HealthCare Corporation
NHC
|
811 M | $ 138.84 | 0.79 % | $ 2.14 B | USA |
|
Novo Integrated Sciences
NVOS
|
7.55 M | - | -13.87 % | $ 1.52 M | USA |
 |
Healthcare Services Group
HCSG
|
1.49 B | $ 19.34 | -0.36 % | $ 1.43 B | USA |
 |
Option Care Health
OPCH
|
3.45 B | $ 33.18 | 0.85 % | $ 5.69 B | USA |
 |
Oak Street Health
OSH
|
438 M | - | 0.03 % | $ 9.53 B | USA |
 |
Phibro Animal Health Corporation
PAHC
|
896 M | $ 40.21 | -1.35 % | $ 1.63 B | USA |
 |
The Pennant Group
PNTG
|
558 M | $ 29.85 | 1.15 % | $ 931 M | USA |
 |
LHC Group
LHCG
|
1.4 B | - | - | $ 5.27 B | USA |
 |
ModivCare
MODV
|
2.37 B | - | -25.23 % | $ 6.12 M | USA |
 |
Select Medical Holdings Corporation
SEM
|
1.18 B | $ 15.3 | -0.94 % | $ 1.91 B | USA |
|
Sanara MedTech
SMTI
|
7.85 M | $ 25.99 | 7.84 % | $ 215 M | USA |
 |
Surgery Partners
SGRY
|
794 M | $ 15.56 | -3.23 % | $ 1.95 B | USA |
 |
SunLink Health Systems
SSY
|
18.3 M | - | 17.98 % | $ 7.81 M | USA |
 |
Tenet Healthcare Corporation
THC
|
8.8 B | $ 199.26 | 0.78 % | $ 19.3 B | USA |
 |
Universal Health Services
UHS
|
7.52 B | $ 222.38 | -0.98 % | $ 14.8 B | USA |
 |
U.S. Physical Therapy
USPH
|
399 M | $ 80.6 | 0.22 % | $ 1.21 B | USA |
 |
Tivity Health
TVTY
|
278 M | - | 0.09 % | $ 1.6 B | USA |